Novel Antidepressants: Conference Sessions

3 sessions at 1 meeting. Newer or emerging antidepressant mechanisms: zuranolone, dextromethorphan-bupropion, neurosteroids, kappa antagonists, etc.

Meetings covering novel antidepressants

September 15–19, 2026 (past)

September 15–19, 2026 · New Orleans, LA

SymposiumMasterClass: The Road to Recovery in MDD: From Partial Response to Remission and Beyond
Christoph U. Correll · Brooke Kempf
Focuses on recognizing clinically meaningful residual depressive symptoms and using adjunctive pharmacologic options to push partial responders toward remission and sustained recovery.
Depression
SymposiumPMDD and Cyclical Mood Disorders: From Diagnosis to Novel Treatments
Pallavi Khanna · Kristin Lasseter
Covers diagnostic criteria and symptom tracking for premenstrual dysphoric disorder, differentiation from MDD and anxiety, and emerging neurosteroid and hormonal treatments. Developed with the International Society of Reproductive Psychiatry.
Measurement-Based Care & Diagnosis Perinatal & Women's Mental Health
SymposiumModern Psychopharmacology for MDD: Switching, Sequencing, and Augmentation Strategies for Partial Responders
Mark Zimmerman · Shelley Matthews
Advanced review of switching protocols, cross-tapering, and augmentation options — lithium, T3, atypicals, dextromethorphan/bupropion, vortioxetine — for patients with incomplete antidepressant response.
Depression Lithium & Mood Stabilizers Treatment-Resistant Depression